We studied the expression of programmed cell death protein 1 (PD-1) and its ligand (PD-L1) in TNBC.
作者研究了程序性细胞死亡蛋白1（PD-1）及其配体（PD-L1）在三阴性乳腺癌中的表达情况。
In gastrointestinal adenocarcinomas, PD-L1-expression was associated with EBER positivity and mismatch-repair deficiency.
胃肠道腺癌中，PD-L1表达与EBER阳性和错配修复缺陷相关。
Other immune cells carry molecular keys or ligands named PD-L1 orPD-L2, which can flip that switch to protect normal tissues from collateral damage.
其他免疫细胞携带有PD-L1或PD-L2的分子键或配体，它们能够保护正常的组织免于附带损伤。
Expression of the immunosuppressive protein B7 homolog 1 (B7-H1), also known as programmed death ligand-1 (PD-L1), is increased in many pathological conditions, including cancer.
免疫抑制蛋白B7同系物1（B7-H1），亦称程序性死亡配体1（PD-L1）在包括癌症等许多病变中表达增高。
PD-L1 immunohistochemistry may have some role in the immunophenotypic differential diagnosis of tumors and pinpointing potential candidates for anti-PD-1/PD-L immune checkpoint therapy.
PD-L1免疫组化可能在肿瘤免疫表型鉴别诊断、精确筛选抗PD-1/PD-L免疫检查点治疗方面有一些作用。
Our results further showed that the PD-1/PD-L1 pathway which could reduce the rate of T lymphocyte apoptosis via the death receptor pathway of endogenous and exogenous death receptor pathway.
我们的结果还进一步表明PD-1／PD-L1途径对T淋巴细胞凋亡的影响是同时通过内源性死亡受体途径和外源性死亡受体途径产生的。
Our results further showed that the PD-1/PD-L1 pathway which could reduce the rate of T lymphocyte apoptosis via the death receptor pathway of endogenous and exogenous death receptor pathway.
我们的结果还进一步表明PD-1／PD-L1途径对T淋巴细胞凋亡的影响是同时通过内源性死亡受体途径和外源性死亡受体途径产生的。
应用推荐